ArticleLevofloxacin versus Clarithromycin-based Therapy for Eradication of Helicobacter Pylori Infection: A Comparative Study
ArticleLevofloxacin versus Clarithromycin-based Therapy for Eradication of Helicobacter Pylori Infection: A Comparative Study
ArticleHelicobacter Pylori Treatment Eradication in Egypt: Standard Clarithromycin-based Triple versus Quadruple Regimen Therapy
ArticleHelicobacter Pylori Treatment Eradication in Egypt: Standard Clarithromycin-based Triple versus Quadruple Regimen Therapy
ArticleVonoprazan versus Conventional Proton Pump Inhibitors Based Regimens in Helicobacter Pylori Eradication Therapy
ArticleVonoprazan versus Conventional Proton Pump Inhibitors Based Regimens in Helicobacter Pylori Eradication Therapy
ArticleVONOPRAZAN VERSUS PROTON PUMP INHIBITORS IN COMBINATION WITH ANTIBIOTICS AS A TRIPLE THERAPY FOR ERADICATION OF CLARITHROMYCIN RESISTANT STRAIN OF HELICOBACTER PYLORI
ArticleVONOPRAZAN VERSUS PROTON PUMP INHIBITORS IN COMBINATION WITH ANTIBIOTICS AS A TRIPLE THERAPY FOR ERADICATION OF CLARITHROMYCIN RESISTANT STRAIN OF HELICOBACTER PYLORI
ArticleA New Sequential Regimen for Treatment of H. Pylori in Naïve and Previously Treated Patients with Traditional Triple Therapy
ArticleA New Sequential Regimen for Treatment of H. Pylori in Naïve and Previously Treated Patients with Traditional Triple Therapy
ArticleROLE OF HELICOBACTER PYLORI ERADICATION USING CLARITHROMYCIN-BASED TRIPLE THERAPY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
ArticleROLE OF HELICOBACTER PYLORI ERADICATION USING CLARITHROMYCIN-BASED TRIPLE THERAPY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
ArticleA Novel Three Drug Rigemen (Moxifloxacin –Omeprazole - Nitazoxanide) in Comparison to Traditional Triple Therapy for Treatment and Eradication of Naïve and Resistant H. Pylori Inf
ArticleA Novel Three Drug Rigemen (Moxifloxacin –Omeprazole - Nitazoxanide) in Comparison to Traditional Triple Therapy for Treatment and Eradication of Naïve and Resistant H. Pylori Inf
ArticleEffectiveness of 14-days course of clarithromycin-based triple therapy as first line therapy for h.pylori infection in egyptian elderly patients
ArticleEffectiveness of 14-days course of clarithromycin-based triple therapy as first line therapy for h.pylori infection in egyptian elderly patients
ArticleA NOVEL THREE DRUG RIGEMEN (MOXIFLOXACIN –OMEPRAZOLE - NITAZOXANIDE) IN COMPARISON TO TRADITIONAL TRIPLE THERAPY FOR TREATMENT AND ERADICATION OF NAÏVE AND RESISTANT H.PYLORI INFE
ArticleA NOVEL THREE DRUG RIGEMEN (MOXIFLOXACIN –OMEPRAZOLE - NITAZOXANIDE) IN COMPARISON TO TRADITIONAL TRIPLE THERAPY FOR TREATMENT AND ERADICATION OF NAÏVE AND RESISTANT H.PYLORI INFE